Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 6, 2023 - The FDA approved Bio-Thera/Sandoz’s Avzivi (bevacizumab-tnjn), biosimilar to Genentech’s Avastin® (bevacizumab).
Download PDF
Return to publications
